The question arises whether changes in liver insulin degradation are normal—and therefore protective of the organism—or whether they may be abnormal, possibly leading to conditions of metabolic risk, such as impaired glucose tolerance and/or diabetes itself. This evidence concerns the gene INS and diabetes mellitus.